Back to search

Article

The clinical effectiveness of tolvaptan in critically ill patients with or without heart disease: A retrospective observational study

2023-05-11

Abstract excerpt

<h4>Background: </h4> Strategies that achieve sufficient diuresis for critically ill patients are needed. Tolvaptan, a selective arginine vasopressin 2 receptor antagonist, has increased cardiac patients' urine volume without worsening their renal function, and we speculated that tolvaptan treatment may also do so in critically ill non-cardiac patients. Here, we sought to determine whether tolvaptan treatment prov...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8a940dfc-e1e0-5f2d-8b93-927704a8ff72
DOI
10.21203/rs.3.rs-2887781/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The clinical effectiveness of tolvaptan in critically ill patients with or without heart disease: A retrospective observational studyDOI 10.21203/rs.3.rs-2887781/v1
The potential effectiveness of tolvaptan independent of cardiac disease in critically ill patients: A retrospective observational studySemantic proximity
Impact of Renin-Angiotensin-Aldosterone System Inhibition on Mortality in Critically Ill COVID-19 Patients with Pre-Existing Hypertension: A Prospective Cohort StudySemantic proximity
Clinical phenotypes according to diuretic combination in acute heart failure.Semantic proximity
Effect of in-hospital treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on mortality and complications in patients hospitalized for COVID-19: a large Spanish cohort studySemantic proximity
Medical Costs and Economic Impact of Hyperkalemia in a Cohort of Heart Failure Patients with Reduced Ejection FractionSemantic proximity
Comparison of renal replacement therapy and renal recovery before and during the COVID-19 pandemic- A single centre observational studySemantic proximity
Risk Factors and Mortality Impact of Acute Kidney Injury in Different ECMO Modalities: A Multicenter Retrospective StudySemantic proximity
Intensive Care Unit Dialysis Practice, Clinical Outcomes, and Associate Factors Among Critically Ill Patients at St.Paul’s Hospital Millennium Medical College in Addis Ababa, Ethiopia: A Prospective Cohort Study DesignSemantic proximity
Are patients on chronic hemodialysis treatment protected against mortality due to COVID-19? A single-center retrospective cohort of patients hospitalized with COVID-19 requiring hemodialysis treatmentSemantic proximity
Cardiovascular Therapy and Mortality in Hospitalized Patients With COVID-19: A Cohort StudySemantic proximity
Hospital Variability in the Use of Vasoactive Agents in Patients Hospitalized for Acute Decompensated Heart Failure: Clinical Phenotypes and Therapeutic ApproachesSemantic proximity
Paxlovid for Treating Hospitalized COVID-19 Patients with Kidney InjurySemantic proximity
Select a neighboring publication to make it the new centre.